Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women

Figure 4

ER/PR/HER2 score and breast cancer-specific mortality risk in women diagnosed with estrogen receptor-positive breast cancer. Adjusted hazard ratio (HR) estimates (95% confidence intervals (CIs)) of breast cancer-specific mortality associated with the estrogen receptor/progesterone receptor/ human epidermal growth factor receptor 2 (ER/PR/HER2) score in all women (A), in white women (B), and in black women (C) with ER-positive invasive breast cancer.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us